Identification of the Cancer Cell Proliferation and Survival Functions of proHB-EGF by Using an Anti-HB-EGF Antibody
Authors:
Open Access
- 21 January 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e54509
Abstract
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family. The membrane-bound proHB-EGF is known to be a precursor of the soluble form of HB-EGF (sHB-EGF), which promotes cell proliferation and survival. While the functions of sHB-EGF have been extensively studied, it is not yet fully understood if proHB-EGF is also involved in cellular signaling events. In this study, we utilized the anti-HB-EGF monoclonal antibodies Y-142 and Y-073, which have differential specificities toward proHB-EGF, in order to elucidate proHB-EGF functions in cancer cells. The biological activities of proHB-EGF were assessed in cell proliferation, caspase activation, and juxtacrine activity assays by using a 3D spheroid culture of NUGC-3 cells. Y-142 and Y-073 exhibited similar binding and neutralizing activities for sHB-EGF. However, only Y-142 bound to proHB-EGF. We could detect the function of endogenously expressed proHB-EGF in a 3D spheroid culture. Blocking proHB-EGF with Y-142 reduced spheroid formation, suppressed cell proliferation, and increased caspase activation in the 3D spheroid culture of NUGC-3 cells. Our results show that proHB-EGF acts as a cell proliferation and cell survival factor in cancer cells. The results suggest that proHB-EGF may play an important role in tumor progression.Keywords
This publication has 39 references indexed in Scilit:
- A Potent Anti-HB-EGF Monoclonal Antibody Inhibits Cancer Cell Proliferation and Multiple Angiogenic Activities of HB-EGFPLOS ONE, 2012
- Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasionBMC Cancer, 2012
- Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membraneJournal of Cell Biology, 2008
- Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligandsCancer Science, 2008
- Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistanceOncogene, 2006
- Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer TherapyCancer Research, 2004
- Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalitiesJournal of Cell Biology, 2003
- Identification of Serum Factor Inducing Ectodomain Shedding of proHB-EGF and Studies of Noncleavable Mutants of proHB-EGFBiochemical and Biophysical Research Communications, 2001
- Contact-dependent Growth Inhibition and Apoptosis of Epidermal Growth Factor (EGF) Receptor-expressing Cells by the Membrane-anchored Form of Heparin-binding EGF-like Growth FactorJournal of Biological Chemistry, 1999
- Induction and Expression of Heparin-Binding EGF-Like Growth Factor in Human Pancreatic CancerBiochemical and Biophysical Research Communications, 1994